Table 1.
Demographic data and laboratory results in preeclampsia and malignant hypertension patients with serous retinal detachment
| Preeclampsia | Malignant hypertension | P value | |
|---|---|---|---|
| Patients, N | 29 | 24 | |
| Age (years) | 33.33 ± 3.44 | 37.29 ± 9.09 | 0.52 * |
| Sex (F/M) | 18/0 | 13/11 | <0.001 † |
| DM history (yes/no) | 4/29 | 4/21 | 0.44 † |
| BMI (kg/m2) | 25.44 ± 4.46 | 25.70 ± 5.72 | 0.85 * |
| Systolic blood pressure (mm Hg) | 155.63 ± 22.01 | 202.63 ± 31.68 | <0.001 * |
| Diastolic blood pressure (mm Hg) | 97.90 ± 14.11 | 123.50 ± 22.91 | <0.001 * |
| Pulse rate (bpm) | 84.90 ± 20.03 | 96.82 ± 13.92 | 0.017 * |
| Etiology of hypertension, N (%) | |||
| Essential | – | 9 (37.5) | |
| Renal artery stenosis | – | 1 (4.2) | |
| Renal parenchymal disease | – | 5 (20.8) | |
| Chronic kidney disease (CKD) | – | 9 (37.5) | |
| Pregnancy complication classification, N (%) | |||
| HELLP incomplete | 8 (27.6) | ||
| HELLP complete | 4 (13.8) | ||
| Eclamptic seizure event | 4 (13.8) | ||
| Clinical laboratory results | |||
| Proteinuria (dipstick positive) | 2.54 ± 0.83 | 1.77 ± 1.30 | 0.020 * |
| BUN (mg/dL) | 15.50 ± 6.64 | 38.57 ± 10.91 | 0.001 * |
| Creatinine (mg/dL) | 0.87 ± 0.41 | 5.23 ± 8.99 | 0.026 * |
| Platelets (/mL) | 153.91 ± 66.93 | 224.50 ± 89.64 | 0.003 * |
| Aspartate transaminase (U/L) | 73.97 ± 17.03 | 24.79 ± 14.53 | 0.23 * |
| Alanine amino transferase (U/L) | 46.12 ± 13.76 | 23.66 ± 16.74 | 0.29 * |
Values are presented as the mean ± standard deviation. Independent t-tests* and Chi-square tests† were used to compare the groups. P values in bold indicate significant differences.
DM diabetes mellitus, BMI body mass index, HELLP hemolysis (H), elevated liver enzymes (EL) and low platelet count (LP)